Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Brief report: Barriers to treatment adherence in pediatric inflammatory bowel disease.

Hommel KA, Baldassano RN.

J Pediatr Psychol. 2010 Oct;35(9):1005-10. doi: 10.1093/jpepsy/jsp126. Epub 2009 Dec 21.

PMID:
20026567
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Barriers to oral medication adherence for adolescents with inflammatory bowel disease.

Ingerski LM, Baldassano RN, Denson LA, Hommel KA.

J Pediatr Psychol. 2010 Jul;35(6):683-91. doi: 10.1093/jpepsy/jsp085. Epub 2009 Sep 23.

PMID:
19776229
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Telehealth behavioral treatment for medication nonadherence: a pilot and feasibility study.

Hommel KA, Hente E, Herzer M, Ingerski LM, Denson LA.

Eur J Gastroenterol Hepatol. 2013 Apr;25(4):469-73. doi: 10.1097/MEG.0b013e32835c2a1b.

PMID:
23325274
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Individually tailored treatment of medication nonadherence.

Hommel KA, Herzer M, Ingerski LM, Hente E, Denson LA.

J Pediatr Gastroenterol Nutr. 2011 Oct;53(4):435-9. doi: 10.1097/MPG.0b013e3182203a91.

PMID:
21519282
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.

Hande S, Wilson-Rich N, Bousvaros A, Zholudev A, Maurer R, Banks P, Makrauer F, Reddy S, Burakoff R, Friedman S.

Inflamm Bowel Dis. 2006 Apr;12(4):251-7.

PMID:
16633046
[PubMed - indexed for MEDLINE]
6.

Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease.

Hommel KA, Davis CM, Baldassano RN.

Inflamm Bowel Dis. 2009 Apr;15(4):589-93. doi: 10.1002/ibd.20798.

PMID:
18985746
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Medication adherence and quality of life in pediatric inflammatory bowel disease.

Hommel KA, Davis CM, Baldassano RN.

J Pediatr Psychol. 2008 Sep;33(8):867-74. doi: 10.1093/jpepsy/jsn022. Epub 2008 Mar 11.

PMID:
18337262
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Barriers to adherence among adolescents with inflammatory bowel disease.

Greenley RN, Stephens M, Doughty A, Raboin T, Kugathasan S.

Inflamm Bowel Dis. 2010 Jan;16(1):36-41. doi: 10.1002/ibd.20988.

PMID:
19434722
[PubMed - indexed for MEDLINE]
9.

Behavioral functioning in youth with inflammatory bowel disease: perceived barriers as mediator of medication adherence.

Reed-Knight B, Lewis JD, Blount RL.

J Pediatr Psychol. 2013 Apr;38(3):309-20. doi: 10.1093/jpepsy/jss122. Epub 2012 Dec 17.

PMID:
23248344
[PubMed - indexed for MEDLINE]
Free Article
10.

Evaluation of a group-based behavioral intervention to promote adherence in adolescents with inflammatory bowel disease.

Hommel KA, Hente EA, Odell S, Herzer M, Ingerski LM, Guilfoyle SM, Denson LA.

Eur J Gastroenterol Hepatol. 2012 Jan;24(1):64-9. doi: 10.1097/MEG.0b013e32834d09f1.

PMID:
21989119
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Identifying youth nonadherence in clinical settings: data-based recommendations for children and adolescents with inflammatory bowel disease.

Greenley RN, Kunz JH, Biank V, Martinez A, Miranda A, Noe J, Telega G, Tipnis NA, Werlin S, Stephens MC.

Inflamm Bowel Dis. 2012 Jul;18(7):1254-9. doi: 10.1002/ibd.21859. Epub 2011 Aug 29.

PMID:
22689633
[PubMed - indexed for MEDLINE]
12.

Use of a screening tool to determine nonadherent behavior in inflammatory bowel disease.

Kane S, Becker B, Harmsen WS, Kurian A, Morisky DE, Zinsmeister AR.

Am J Gastroenterol. 2012 Feb;107(2):154-60. doi: 10.1038/ajg.2011.317.

PMID:
22306937
[PubMed - indexed for MEDLINE]
13.

Treatment adherence in adolescents with inflammatory bowel disease: the collective impact of barriers to adherence and anxiety/depressive symptoms.

Gray WN, Denson LA, Baldassano RN, Hommel KA.

J Pediatr Psychol. 2012 Apr;37(3):282-91. doi: 10.1093/jpepsy/jsr092. Epub 2011 Nov 10.

PMID:
22080456
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Oral medication adherence and disease severity in pediatric inflammatory bowel disease.

Hommel KA, Denson LA, Baldassano RN.

Eur J Gastroenterol Hepatol. 2011 Mar;23(3):250-4. doi: 10.1097/MEG.0b013e328344019c.

PMID:
21304318
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Association of disease, adolescent, and family factors with medication adherence in pediatric inflammatory bowel disease.

Reed-Knight B, Lewis JD, Blount RL.

J Pediatr Psychol. 2011 Apr;36(3):308-17. doi: 10.1093/jpepsy/jsq076. Epub 2010 Aug 26.

PMID:
20798185
[PubMed - indexed for MEDLINE]
Free Article
16.

Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease.

van Schaik FD, van Oijen MG, Smeets HM, van der Heijden GJ, Siersema PD, Oldenburg B.

Gut. 2012 Feb;61(2):235-40. doi: 10.1136/gut.2011.237412. Epub 2011 May 20.

PMID:
21602529
[PubMed - indexed for MEDLINE]
17.

Medication-taking behavior in a cohort of patients with inflammatory bowel disease.

Bernal I, Domènech E, Garcia-Planella E, Marín L, Mañosa M, Navarro M, Cabré E, Gassull MA.

Dig Dis Sci. 2006 Dec;51(12):2165-9. Epub 2006 Nov 4.

PMID:
17086434
[PubMed - indexed for MEDLINE]
18.

The future of inflammatory bowel disease care.

Sandborn WJ.

Rev Gastroenterol Disord. 2009 Summer;9(3):E69-77. Review.

PMID:
19898267
[PubMed - indexed for MEDLINE]
19.

Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease.

Gisbert JP, Chaparro M, Gomollón F.

World J Gastroenterol. 2011 Aug 14;17(30):3467-78. doi: 10.3748/wjg.v17.i30.3467.

PMID:
21941413
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

[Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease].

Gisbert JP, Gomollón F, Maté J, Pajares JM.

Gastroenterol Hepatol. 2002 Jun-Jul;25(6):401-15. Review. Spanish. No abstract available.

PMID:
12069704
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk